<DOC>
	<DOCNO>NCT01241487</DOCNO>
	<brief_summary>This study assess efficacy fix combination Valsartan Amlodipine hypertensive patient uncontrolled monotherapy .</brief_summary>
	<brief_title>A National Multicentre Study Assess Efficacy Fixed Combination Valsartan Amlodipine Hypertensive Patients Not Controlled Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<criteria>Patient uncontrolled monotherapy least 8 week , B.P. &gt; /= 140/90 mmHg non diabetic &gt; /= 130/80 mmHg diabetic Patient B.P. &gt; = 180/110 mmHg non diabetic &gt; = 160/100 mmHg diabetic Type 1 Diabetes uncontrolled type 2 Diabetes . PCI last 12 month . Concomitant unstable angina . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension , Valsartan/Amlodipine ,</keyword>
</DOC>